Literature DB >> 19494557

Chorioamnionitis, postnatal factors and proinflammatory response in the pathogenetic sequence of bronchopulmonary dysplasia.

Christian P Speer1.   

Abstract

Pulmonary inflammation has a central role in the multifactorial and complex pathogenesis of bronchopulmonary dysplasia. Pre- and postnatal factors such as chorioamnionitis, oxygen toxicity, mechanical ventilation and postnatal infections can induce and perpetuate an injurious and complex inflammatory response in the airways and lung tissue of very immature infants. This inflammatory process is characterized by the accumulation of inflammatory cells and an arsenal of proinflammatory mediators such as cytokines, toxic oxygen radicals, lipid mediators and potent proteases. An imbalance between pro- and anti-inflammatory factors favoring the proinflammatory process can be considered as a hallmark of lung injury. In addition, impaired mechanisms of tissue remodeling and repair together with a subnormal generation of growth factors could affect alveolarization and vascular development with lifelong consequences for the infants with bronchopulmonary dysplasia. (c) 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19494557     DOI: 10.1159/000209301

Source DB:  PubMed          Journal:  Neonatology        ISSN: 1661-7800            Impact factor:   4.035


  44 in total

1.  Profound lack of interleukin (IL)-12/IL-23p40 in neonates born early in gestation is associated with an increased risk of sepsis.

Authors:  Pascal M Lavoie; Qing Huang; Elyse Jolette; Mihoko Whalen; Anne Monique Nuyt; Francois Audibert; David P Speert; Thierry Lacaze-Masmonteil; Hugo Soudeyns; Tobias R Kollmann
Journal:  J Infect Dis       Date:  2010-10-26       Impact factor: 5.226

Review 2.  Intermittent hypoxic episodes in preterm infants: do they matter?

Authors:  Richard J Martin; Katherine Wang; Ozge Köroğlu; Juliann Di Fiore; Prabha Kc
Journal:  Neonatology       Date:  2011-10-03       Impact factor: 4.035

3.  Silencing hyperoxia-induced C/EBPα in neonatal mice improves lung architecture via enhanced proliferation of alveolar epithelial cells.

Authors:  Guang Yang; Maurice D Hinson; Jessica E Bordner; Qing S Lin; Amal P Fernando; Ping La; Clyde J Wright; Phyllis A Dennery
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-05-13       Impact factor: 5.464

4.  Interleukin-22: biomarker of maternal and fetal inflammation?

Authors:  Iliana Bersani; Maria Pia De Carolis; Dirk Foell; Toni Weinhage; Esther Diana Rossi; Sara De Carolis; Serena Antonia Rubortone; Costantino Romagnoli; Christian Paul Speer
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

5.  Elastase inhibitory activity of airway α1-antitrypsin is protected by treatment with a catalytic antioxidant in a baboon model of severe bronchopulmonary dysplasia.

Authors:  Cagatay Karaaslan; Hiroshi Hirakawa; Ryuji Yasumatsu; Ling-Yi L Chang; Richard A Pierce; James D Crapo; Sule Cataltepe
Journal:  Pediatr Res       Date:  2011-10       Impact factor: 3.756

6.  In vitro and in vivo characterization of poractant alfa supplemented with budesonide for safe and effective intratracheal administration.

Authors:  Francesca Ricci; Chiara Catozzi; Francesca Ravanetti; Xabier Murgia; Francesco D'Aló; Natalia Macchidani; Elisa Sgarbi; Valentina Di Lallo; Federica Saccani; Marisa Pertile; Antonio Cacchioli; Silvia Catinella; Gino Villetti; Maurizio Civelli; Francesco Amadei; Fabio Franco Stellari; Barbara Pioselli; Fabrizio Salomone
Journal:  Pediatr Res       Date:  2017-08-23       Impact factor: 3.756

7.  Effects of hyperoxia on alveolar and pulmonary vascular development in germ-free mice.

Authors:  Kalsang Dolma; Amelia E Freeman; Gabriel Rezonzew; Gregory A Payne; Xin Xu; Tamas Jilling; J Edwin Blalock; Amit Gaggar; Namasivayam Ambalavanan; Charitharth Vivek Lal
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-10-23       Impact factor: 5.464

8.  Urinary ß2-microglobulin in very preterm neonates with chorioamnionitis.

Authors:  Shigeru Nishimaki; Yoshio Shima; Miho Sato; Hiromi An; Shujiro Fujita; Shiho Iwasaki; Haruko Horiguchi; Kazuo Seki; Shumpei Yokota
Journal:  Pediatr Nephrol       Date:  2011-06-11       Impact factor: 3.714

Review 9.  Targeting inflammation to prevent bronchopulmonary dysplasia: can new insights be translated into therapies?

Authors:  Clyde J Wright; Haresh Kirpalani
Journal:  Pediatrics       Date:  2011-06-06       Impact factor: 7.124

10.  Patterns of blood protein concentrations of ELGANs classified by three patterns of respiratory disease in the first 2 postnatal weeks.

Authors:  Matthew Laughon; Carl Bose; Elizabeth N Allred; T Michael O'shea; Richard A Ehrenkranz; Linda J VAN Marter; Alan Leviton
Journal:  Pediatr Res       Date:  2011-09       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.